Serum lipoprotein lipase mass: Clinical significance of its measurement
Open accessAbstract
Lipoprotein lipase (LPL) is a lipolytic enzyme involved in catalyzing hydrolysis of triglycerides (TG) in chylomicrons and very low-density lipoprotein (VLDL) particles. Over the last decade, increasing attention has been paid to the clinical significance of measuring serum LPL protein mass without heparin injection to the study subjects. In earlier studies, this marker was utilized to classify LPL deficient subjects, which is an extremely rare metabolic disorder with a frequency of one in one million. Later, researchers paid more attention to the clinical significance of measuring this parameter in more common metabolic disorders. Studies have shown that pre-heparin plasma or serum LPL mass has significant relationships with serum lipids and lipoproteins, visceral fat area, insulin resistance, and even the development of coronary atherosclerosis in cross-sectional studies, although this might be a metabolic surrogate marker with almost no catalytic activities, which does not appear to be involved in catalyzing hydrolysis of TG in TG-rich lipoproteins. Recently, a prospective study has demonstrated that low serum LPL concentration predicts future coronary events. Taken together, we suggest that pre-heparin LPL mass in plasma or sera provide us with useful and important information on the development of metabolic disorders leading to atherosclerotic disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Heavy or prolonged aerobic exercise episodes can significantly increase post-heparin plasma LPL activity, thus promoting LPL-mediated TG hydrolysis.
“Ferguson et al. [63] reported that heavy or prolonged aerobic exercise episodes could significantly increase post-heparin plasma LPL activity, thus promoted LPL-mediated TG hydrolysis.”
From Effects of aerobic exercise on lipids and lipoproteins (2017) · cites this paper as [63]
Cites
Rimm, E. B., Stampfer, M. J., Giovannucci, E. L., Ascherio, A., Spiegelman, D. L., Colditz, G. A., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117385 · Cited by 840 · see citing works
Lipolytic Enzymes and Plasma Lipoprotein Metabolism
Nilsson‐Ehle, P., Garfinkel, A. S., & Schotz, M. C. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.003315 · Cited by 754 · see citing works
Beisiegel†, U., Weber, W., & Bengtsson-Olivecrona, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8342 · Cited by 626 · see citing works
Havel, R. J., Kane, J. P., & Kashyap, M. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107171 · Cited by 528 · see citing works
Nakamura, T., Tokunaga, K., Shimomura, I., Nishida, M., Yoshida, S., Kotani, K., Islam, A. H. M. W., Keno, Y., Kobatake, T., Nagai, Y., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90025-6 · Cited by 429 · see citing works
Abdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. A. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 292 · see citing works
Postprandial triglyceride response in visceral obesity in men
Couillard, C., Bergeron, N., Prud'homme, D., Bergeron, J., Tremblay, A., Bouchard, C., Mauriège, P., & Després, J. P. (1998) · Diabetes · doi:10.2337/diabetes.47.6.953 · Cited by 271 · see citing works
Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W., & Swenson, T. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42208-9 · Cited by 257 · see citing works
(2001) · Medical Entomology and Zoology · Cited by 227 · see citing works
Tornvall, P., Olivecrona, G., Karpe, F., Hamsten, A., & Olivecrona, T. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.8.1086 · Cited by 172 · see citing works
Walton, C., Lees, B., Crook, D., Worthington, M., Godsland, I. F., & Stevenson, J. C. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80220-4 · Cited by 170 · see citing works
Binding of lipoprotein lipase to endothelial cells in culture.
Cheng, C. F., Oosta, G. M., Bensadoun, A., & ROSENBERG, R. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42980-8 · Cited by 162 · see citing works
Merkel, M., Kako, Y., Radner, H., Cho, I. S., Ramasamy, R., Brunzell, J. D., Goldberg, I. J., & Breslow, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13841 · Cited by 150 · see citing works
Vilella, E., Joven, J., Fernandez‐Borja, M., Vilaró, S., Brunzell, J., Olivecrona, T., & Bengtsson-Olivecrona, G. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36948-0 · Cited by 148 · see citing works
Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia
von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2925 · Cited by 141 · see citing works
Identification and characterization of the endothelial cell surface lipoprotein lipase receptor.
Saxena, U., Klein, M. G., & Goldberg, I. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47402-4 · Cited by 89 · see citing works
Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome
Saiki, A., Oyama, T., Endo, K., Ebisuno, M., Ohira, M., Koide, N., Murano, T., Miyashita, Y., & Shirai, K. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.08.004 · Cited by 82 · see citing works
Nykjær, A., Nielsen, M. S., Lõokene, A., Meyer, N., Røigaard-Petersen, H., Etzerodt, M., Beisiegel†, U., Olivecrona, G., & Gliemann, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31759-9 · Cited by 80 · see citing works
Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.
Hanyu, O., Miida, T., Obayashi, K., Ikarashi, T., Soda, S., Kaneko, S., Hirayama, S., Suzuki, K., Nakamura, Y., Yamatani, K., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.034 · Cited by 77 · see citing works
Lipolysis and lipid movement in a membrane model. Action of lipoprotein lipase.
Scow, R. O., Desnuelle, P., & Verger, R. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50389-6 · Cited by 74 · see citing works
Watanabe, H., Miyashita, Y., Murano, T., Hiroh, Y., Itoh, Y., & Shirai, K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00012-x · Cited by 69 · see citing works
Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease
Rip, J., Nierman, M. C., Wareham, N. J., Luben, R., Bingham, S. A., Day, N., van Miert, J. N. I., Hutten, B. A., Kastelein, J. J. P., Kuivenhoven, J. A., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201038.47949.56 · Cited by 67 · see citing works
Chappell, D. A., Inoue, I., Fry, G. L., Pladet, M. W., Bowen, S. L., Iverius, P., Lalouel, J.-M., & Strickland, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32409-2 · Cited by 64 · see citing works
The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum
Shirai, K., Itoh, Y., Sasaki, H., Totsuka, M., Murano, T., Watanabe, H., & Miyashita, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00063-7 · Cited by 64 · see citing works
Miyashita, Y., Shirai, K., Itoh, Y., Sasaki, H., Totsuka, M., Murano, T., & Watanabe, H. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00369-2 · Cited by 62 · see citing works
Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis
Hitsumoto, T., Ohsawa, H., Uchi, T., Noike, H., Kanai, M., Yoshinuma, M., Miyashita, Y., Watanabe, H., & Shirai, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00413-5 · Cited by 61 · see citing works
Kern, P. A., Martin, R., Carty, J., Ij, G., & Ong, J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42756-7 · Cited by 55 · see citing works
Kobayashi, J., Saito, K., Fukamachi, I., Taira, K., Takahashi, K., Bujo, H., & Saito, Y. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-16230 · Cited by 49 · see citing works
Self-citationZheng, C., Murdoch, S. J., Brunzell, J. D., & Sacks, F. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000203512.01007.3d · Cited by 48 · see citing works
Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation
Taira, Hikita, Kobayashi, Bujo, Takahashi, Murano, Morisaki, & Saito (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00454.x · Cited by 47 · see citing works
Pitavastatin Enhanced Lipoprotein Lipase Expression in 3T3-L1 Preadipocytes
Saiki, A., Murano, T., Watanabe, F., Oyama, T., Miyashita, Y., & Shirai, K. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.163 · Cited by 45 · see citing works
Endo, K., Miyashita, Y., Saiki, A., Oyama, T., Koide, N., Ozaki, H., Otsuka, M., Ito, Y., & Shirai, K. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.341 · Cited by 44 · see citing works
Defective enzyme protein in lipoprotein lipase deficiency
Auwerx, J. H., Babirak, S. P., Fujimoto, W. Y., Iverius, P., & Brunzell, J. D. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00255.x · Cited by 44 · see citing works
Kobayashi, J., Tashiro, J., Murano, S., Morisaki, N., & Saitō, Y. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00485.x · Cited by 44 · see citing works
Self-citationEnhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration
Totsuka, M., Miyashita, Y., Ito, Y., Watanabe, H., Murano, T., & Shirai, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00394-4 · Cited by 43 · see citing works
Kobayashi, J., Kusunoki, M., Murase, Y., Kawashiri, M., Higashikata, T., Miwa, K., Katsuda, S., Takata, M., Asano, A., Nohara, A., et al. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870318 · Cited by 42 · see citing works
Self-citationHirano, T., Nishioka, F., & Murakami, T. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.021 · Cited by 34 · see citing works
de Vries, R., Wolffenbuttel, B. H. R., Sluiter, W. J., van Tol, A., & Dullaart, R. P. F. (2005) · PubMed · Cited by 31 · see citing works
Taira, K., Bujo, H., Kobayashi, J., Takahashi, K., Miyazaki, A., & Saitō, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00577-9 · Cited by 29 · see citing works
Self-citationEffect of troglitazone on plasma lipid metabolism and lipoprotein lipase
Kobayashi, J., Nagashima, I., Hikita, M., Bujo, H., Takahashi, K., OTABE, M., Morisaki, N., & Saito, Y. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00920.x · Cited by 29 · see citing works
Self-citationHitsumoto, T., Yoshinaga, K., Aoyagi, K., Sakurai, T., Kanai, M., Uchi, T., Noike, H., Ohsawa, H., Watanabe, H., & Shirai, K. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.163 · Cited by 28 · see citing works
de Man, F. H. A. F., de Beer, F., van der Laarse, A., Jansen, H., Leuven, J. A. G., Souverijn, J. H. M., Vroom, T. F. F. P., Schoormans, S. C. M., Fruchart, J., Havekes, L. M., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00409-3 · Cited by 20 · see citing works
High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease
Tornvall, P., Karpe, F., Proudler, A. J., Båvenholm, P., Landou, C., Olivecrona, T., & Hamsten, A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90118-3 · Cited by 20 · see citing works
Kobayashi, J., Maruyama, T., Masuda, M., & Shinomiya, M. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00701-x · Cited by 19 · see citing works
Self-citationKobayashi, J., Maruyama, T., Watanabe, H., Kudoh, A., Tateishi, S., Sasaki, T., Murano, S., & Watanabe, M. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00160-8 · Cited by 16 · see citing works
Self-citationKobayashi, J., Takahashi, K., Tashiro, J., Shirai, K., Saito, Y., Yoshida, S., Hashimoto, H., Fukamachi, I., NIIHARA, K., & Sasaki, N. (1994) · PubMed · Cited by 10 · see citing works
Self-citationEffect of Bezafibrate Treatment on the Altered Lipoprotein Profiles in Hypertriglyceridemic Subjects
Norioka, M., Suzuki, M., Ryomoto, K., Ikebuchi, M., & Harano, Y. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.198 · Cited by 9 · see citing works
Herranz, L., Zapata, A., Grande, C., Megía, A., & Pallardo, L. F. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978853 · Cited by 9 · see citing works
Kobayashi, J., Tateishi, S., Maruyama, T., Kudoh, A., & Murano, S. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00244-4 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Effects of aerobic exercise on lipids and lipoproteins
Wang, Y., & Xu, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0515-5 · Cited by 436 · see citing works
Mechanisms by which diabetes increases cardiovascular disease
Gleissner, C. A., Galkina, E., Nadler, J. L., & Ley, K. F. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.12.005 · Cited by 97 · see citing works
Meyer, B. J., Stewart, F. M., Brown, E. A., Cooney, J., Nilsson, S., Olivecrona, G., Ramsay, J. E., Griffin, B. A., CASLAKE, M. J., & Freeman, D. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3481 · Cited by 57 · see citing works
A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism
Gronek, P., Wieliński, D., Cygański, P., Rynkiewicz, A., Zając, A., Maszczyk, A., Gronek, J., Podstawski, R., Czarny, W., Balkó, Š., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0516 · Cited by 50 · see citing works
Lipoprotein lipase and atherosclerosis
Kobayashi, J., & Mabuchi, H. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215590451 · Cited by 40 · see citing works
Self-citationNakajima, K., Kobayashi, J., Mabuchi, H., Nakano, T., Tokita, Y., Nagamine, T., Imamura, S., Ai, M., Otokozawa, S., & Schaefer, E. J. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.009307 · Cited by 39 · see citing works
Self-citationDecreased Lipoprotein Lipase in Obstructive Sleep Apnea Syndrome
Iesato, K., Tatsumi, K., Saibara, T., Nakamura, A., Terada, J., Tada, Y., Sakao, S., Tanabe, N., Takiguchi, Y., & Kuriyama, T. (2007) · Circulation Journal · doi:10.1253/circj.71.1293 · Cited by 38 · see citing works
Miyashita, M., Eto, M., Sasai, H., Tsujimoto, T., Nomata, Y., & Tanaka, K. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2337 · Cited by 28 · see citing works
Apryatin, S. A., Shipelin, V. A., Trusov, N. V., Mzhelskaya, K. V., Evstratova, V. S., Kirbaeva, N. V., Soto, J. S., Fesenko, Z. S., Gainetdinov, R. R., & Gmoshinski, I. V. (2019) · Physiological Reports · doi:10.14814/phy2.13987 · Cited by 28 · see citing works
Wierzbicki, A. S. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch44 · Cited by 26 · see citing works
Hanyu, O., Miida, T., Kosuge, K., Ito, T., Soda, S., Hirayama, S., Wardaningsih, E., Fueki, Y., Obayashi, K., & Aizawa, Y. (2007) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2007.06.015 · Cited by 26 · see citing works
Miyashita, M., & Tokuyama, K. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507853438 · Cited by 23 · see citing works
Kurooka, N., Eguchi, J., & Wada, J. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14056 · Cited by 17 · see citing works
Terazawa-Watanabe, M., Tsuboi, A., Fukuo, K., & Kazumi, T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0023 · Cited by 16 · see citing works
Ağırbaşlı, M. A., Sumerkan, M. C., Eren, F., & Ağırbaşlı, D. (2010) · Heart and Vessels · doi:10.1007/s00380-010-0077-1 · Cited by 16 · see citing works
Yoshikawa, K., Okada, T., Munakata, S., Okahashi, A., Yonezawa, R., Makimoto, M., Hosono, S., Takahashi, S., Mugishima, H., & Yamamoto, T. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.25 · Cited by 16 · see citing works
Relationship between Serum Cholesterol Efflux Capacity and Glucose Intolerance in Japanese-Americans
Kubota, M., Nakanishi, S., Hirano, M., Maeda, S., Yoneda, M., Awaya, T., Yamane, K., & Kohno, N. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24315 · Cited by 15 · see citing works
Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes
Mancera‐Romero, J., Sánchez-Chaparro, M. Á., Rioja, J., Ariza, M. J., Olivecrona, G., González‐Santos, P., & Valdivielso, P. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0434-x · Cited by 13 · see citing works
Yu, X., Lu, J., Li, J., Guan, W. X., Deng, S., Deng, Q., Ye, H., Han, W., Yu, Y., & Zhang, R. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.46821 · Cited by 13 · see citing works
Lipoprotein lipase does not increase significantly in the postprandial plasma
Ishiyama, N., Sakamaki, K., Shimomura, Y., Kotani, K., Tsuzaki, K., Sakane, N., Miyashita, K., Fukamachi, I., Kobayashi, J., Stanhope, K. L., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.035 · Cited by 12 · see citing works
Self-citationTamura, S., Koike, Y., Takeda, H., Koike, T., Izumi, Y., Nagasaka, R., Tsunoda, T., Tori, M., Ogawa, K., Bamba, T., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.013 · Cited by 12 · see citing works
Costa, R. R., Buttelli, A. C. K., Fagundes, A. D. O., Fonseca, G. A., Pilla, C., Barreto, M. F., Viero, P. A., da Rocha, V. D. M. B., Alberton, C. L., & Kruel, L. F. M. (2020) · Clinics · doi:10.6061/clinics/2020/e1183 · Cited by 10 · see citing works
Hitsumoto, T., Takahashi, M., Iizuka, T., & Shirai, K. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e547 · Cited by 10 · see citing works
Shin, E.-J., Park, N.-Y., Jang, Y., Oh, H., Jeong, J., Lim, Y., & Lee, M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0251-9 · Cited by 10 · see citing works
The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver
Daniele, S. M., Montenegro, S. M., Tarrés, M. C., Picena, J. C., & Martínez, S. M. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-15 · Cited by 9 · see citing works
Maser, R. E., Lenhard, M. J., Pohlig, R. T., & Balagopal, P. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.12.002 · Cited by 9 · see citing works
Relationship between Two AMI Risk Factors: Low Serum Lipoprotein Lipase Mass and Hypoadiponectinemia
Hitsumoto, T., Takahashi, M., Iizuka, T., & Shirai, K. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6197 · Cited by 7 · see citing works
Onat, A., Hergenç, G., Ağırbaşlı, M. A., Kaya, Z., Can, G., & Erginel‐Ünaltuna, N. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.018 · Cited by 7 · see citing works
Minamizuka, T., Kobayashi, J., Tada, H., Miyashita, K., Koshizaka, M., Maezawa, Y., Ono, H., & Yokote, K. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.031 · Cited by 5 · see citing works
Self-citationApolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia
Yoshino, Y., Okada, T., Abe, Y., Odaka, M., Kuromori, Y., Yonezawa, R., Iwata, F., & Mugishima, H. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.08.192 · Cited by 4 · see citing works
Torkamaneh, S., Gené‐Morales, J., Juesas, Á., Flández, J., Hammami, R., Rafieian-Kopaei, M., & Colado, J. C. (2021) · Autumn Conferences of Sports Science · doi:10.14198/jhse.2021.16.proc2.47 · Cited by 1 · see citing works
Mark, P., Schrøder, J., Jensen, A. K., Prickett, T. C. R., Prescott, E., & Goetze, J. P. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101859 · Cited by 1 · see citing works
Costa, R. R. (2011) · Americanae (AECID Library) · doi:10.13140/rg.2.2.26954.16328 · Cited by 1 · see citing works
Abe, Y., Kikuchi, T., Nagasaki, K., Hiura, M., Tanaka, Y., Ogawa, Y., & Uchiyama, M. (2011) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.20.13
Özgönül, C., Sertoğlu, E., Gökçe, G., & Ayyıldız, Ö. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-015-2994-2
- Authors
- Kobayashi, J., Nohara, A., Kawashiri, M.-A., Inazu, A., Koizumi, J., Nakajima, K., & Mabuchi, H.
- Affiliations
- Kanazawa University (JP)
- Kanazawa University Hospital (JP)
- Corresponding author
- Kobayashi, Junji
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 378
- Issue
- 1-2
- Pages
- 7-12
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2028926882
- Cited by
- 35
- References
- 49
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 0.33
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Clinica Chimica Acta (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- lipoprotein lipase, lipoprotein lipase deficiency, lipolysis, atherosclerosis, coronary events, insulin resistance, visceral fat, serum lipids, metabolic biomarkers
- MeSH terms
- Hypolipidemic Agents, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Lipoprotein Lipase, Lipoproteins, HDL, Lipoproteins, LDL, Intra-Abdominal Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
